[IL-17/IL-23: a new therapeutic target in inflammatory bowel diseases].
Malamut
G
G
Service d'Hépatogastroentérologie, Hôpital Européen Georges-Pompidou, 20 Rue Leblanc, 75015 Paris, France. georgia.malamut@egp.aphp.fr
D000911:Antibodies, Monoclonal / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000276:immunology*; D020381:Interleukin-17 / Q000276:immunology*; D053759:Interleukin-23 / Q000276:immunology*
D000911:Antibodies, Monoclonal; D020381:Interleukin-17; D053759:Interleukin-23